Table of Contents 1 Study Coverage 1.1 Age Related Macular Degeneration Drug Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Product 1.4.2 Lucentis 1.4.3 Eylea 1.4.4 Avastin 1.4.5 Other 1.5 Market by End User 1.5.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by End User 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Age Related Macular Degeneration Drug Market Size 2.1.1 Global Age Related Macular Degeneration Drug Revenue 2014-2025 2.1.2 Global Age Related Macular Degeneration Drug Sales 2014-2025 2.2 Age Related Macular Degeneration Drug Growth Rate by Regions 2.2.1 Global Age Related Macular Degeneration Drug Sales by Regions 2.2.2 Global Age Related Macular Degeneration Drug Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Age Related Macular Degeneration Drug Sales by Manufacturers 3.1.1 Age Related Macular Degeneration Drug Sales by Manufacturers 3.1.2 Age Related Macular Degeneration Drug Sales Market Share by Manufacturers 3.1.3 Global Age Related Macular Degeneration Drug Market Concentration Ratio (CR5 and HHI) 3.2 Age Related Macular Degeneration Drug Revenue by Manufacturers 3.2.1 Age Related Macular Degeneration Drug Revenue by Manufacturers (2014-2019) 3.2.2 Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2014-2019) 3.3 Age Related Macular Degeneration Drug Price by Manufacturers 3.4 Age Related Macular Degeneration Drug Manufacturing Base Distribution, Product Types 3.4.1 Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Age Related Macular Degeneration Drug Product Type 3.4.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Age Related Macular Degeneration Drug Sales by Product 4.2 Global Age Related Macular Degeneration Drug Revenue by Product 4.3 Age Related Macular Degeneration Drug Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Age Related Macular Degeneration Drug Breakdown Data by End User 6 North America 6.1 North America Age Related Macular Degeneration Drug by Countries 6.1.1 North America Age Related Macular Degeneration Drug Sales by Countries 6.1.2 North America Age Related Macular Degeneration Drug Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Age Related Macular Degeneration Drug by Product 6.3 North America Age Related Macular Degeneration Drug by End User 7 Europe 7.1 Europe Age Related Macular Degeneration Drug by Countries 7.1.1 Europe Age Related Macular Degeneration Drug Sales by Countries 7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Age Related Macular Degeneration Drug by Product 7.3 Europe Age Related Macular Degeneration Drug by End User 8 Asia Pacific 8.1 Asia Pacific Age Related Macular Degeneration Drug by Countries 8.1.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Countries 8.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Age Related Macular Degeneration Drug by Product 8.3 Asia Pacific Age Related Macular Degeneration Drug by End User 9 Central & South America 9.1 Central & South America Age Related Macular Degeneration Drug by Countries 9.1.1 Central & South America Age Related Macular Degeneration Drug Sales by Countries 9.1.2 Central & South America Age Related Macular Degeneration Drug Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Age Related Macular Degeneration Drug by Product 9.3 Central & South America Age Related Macular Degeneration Drug by End User 10 Middle East and Africa 10.1 Middle East and Africa Age Related Macular Degeneration Drug by Countries 10.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Countries 10.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Age Related Macular Degeneration Drug by Product 10.3 Middle East and Africa Age Related Macular Degeneration Drug by End User 11 Company Profiles 11.1 Regeneron Pharmaceuticals 11.1.1 Regeneron Pharmaceuticals Company Details 11.1.2 Company Business Overview 11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered 11.1.5 Regeneron Pharmaceuticals Recent Development 11.2 Bayer HealthCare 11.2.1 Bayer HealthCare Company Details 11.2.2 Company Business Overview 11.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered 11.2.5 Bayer HealthCare Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Company Business Overview 11.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Novartis Age Related Macular Degeneration Drug Products Offered 11.3.5 Novartis Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Company Business Overview 11.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Roche Age Related Macular Degeneration Drug Products Offered 11.4.5 Roche Recent Development 11.5 Kanghong Pharma 11.5.1 Kanghong Pharma Company Details 11.5.2 Company Business Overview 11.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered 11.5.5 Kanghong Pharma Recent Development 12 Future Forecast 12.1 Age Related Macular Degeneration Drug Market Forecast by Regions 12.1.1 Global Age Related Macular Degeneration Drug Sales Forecast by Regions 2019-2025 12.1.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Regions 2019-2025 12.2 Age Related Macular Degeneration Drug Market Forecast by Product 12.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Product 2019-2025 12.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Product 2019-2025 12.3 Age Related Macular Degeneration Drug Market Forecast by End User 12.4 North America Age Related Macular Degeneration Drug Forecast 12.5 Europe Age Related Macular Degeneration Drug Forecast 12.6 Asia Pacific Age Related Macular Degeneration Drug Forecast 12.7 Central & South America Age Related Macular Degeneration Drug Forecast 12.8 Middle East and Africa Age Related Macular Degeneration Drug Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Age Related Macular Degeneration Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Age Related Macular Degeneration Drug Product Picture Table Age Related Macular Degeneration Drug Market Segments Table Key Manufacturers Age Related Macular Degeneration Drug Covered Table Global Age Related Macular Degeneration Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Age Related Macular Degeneration Drug Sales Market Share by Product 2014-2025 Figure Lucentis Product Picture Table Major Manufacturers of Lucentis Figure Eylea Product Picture Table Major Manufacturers of Eylea Figure Avastin Product Picture Table Major Manufacturers of Avastin Figure Other Product Picture Table Major Manufacturers of Other Table Global Age Related Macular Degeneration Drug Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospitals Figure Clinics Figure Other Figure Age Related Macular Degeneration Drug Report Years Considered Figure Global Age Related Macular Degeneration Drug Market Size 2014-2025 (Million US$) Figure Global Age Related Macular Degeneration Drug Sales 2014-2025 (K Units) Table Global Age Related Macular Degeneration Drug Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Age Related Macular Degeneration Drug Sales by Regions 2014-2019 (K Units) Table Global Age Related Macular Degeneration Drug Sales Market Share by Regions 2014-2019 Figure Global Age Related Macular Degeneration Drug Sales Market Share by Regions 2014-2019 Figure 2018 Global Age Related Macular Degeneration Drug Sales Market Share by Regions Table Global Age Related Macular Degeneration Drug Revenue by Regions 2014-2019 (Million US$) Table Global Age Related Macular Degeneration Drug Revenue Market Share by Regions 2014-2019 Figure Global Age Related Macular Degeneration Drug Revenue Market Share by Regions 2014-2019 Figure 2018 Global Age Related Macular Degeneration Drug Revenue Market Share by Regions Table Global Age Related Macular Degeneration Drug Sales by Manufacturers (2014-2019) (K Units) Table Global Age Related Macular Degeneration Drug Sales Share by Manufacturers (2014-2019) Figure Global Age Related Macular Degeneration Drug Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Age Related Macular Degeneration Drug Revenue by Manufacturers (2014-2019) (Million USD) Table Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2014-2019) Figure Age Related Macular Degeneration Drug Value Share by Manufacturers in 2018 Table Key Manufacturers Age Related Macular Degeneration Drug Price (2014-2019) (USD/Unit) Table Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Age Related Macular Degeneration Drug Product Type Table Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table Global Age Related Macular Degeneration Drug Sales Share by Product (2014-2019) Figure Global Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure Global Age Related Macular Degeneration Drug Sales Market Share by Product in 2018 Table Global Age Related Macular Degeneration Drug Revenue by Product (2014-2019) (Million US$) Table Global Age Related Macular Degeneration Drug Revenue Share by Product (2014-2019) Figure Global Age Related Macular Degeneration Drug Revenue Market Share by Product (2014-2019) Figure Global Age Related Macular Degeneration Drug Revenue Market Share by Product in 2018 Table Age Related Macular Degeneration Drug Price by Product 2014-2019 (USD/Unit) Table Global Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table Global Age Related Macular Degeneration Drug Sales Share by End User (2014-2019) Figure Global Sales Age Related Macular Degeneration Drug Market Share by End User (2014-2019) Figure Global Sales Age Related Macular Degeneration Drug Market Share by End User in 2018 Figure North America Age Related Macular Degeneration Drug Sales Growth Rate 2014-2019 (K Units) Figure North America Age Related Macular Degeneration Drug Revenue Growth Rate 2014-2019 (Million US$) Table North America Age Related Macular Degeneration Drug Sales by Countries (2014-2019) (K Units) Table North America Age Related Macular Degeneration Drug Sales Market Share by Countries (2014-2019) Figure 2018 North America Age Related Macular Degeneration Drug Sales Market Share by Countries Table North America Age Related Macular Degeneration Drug Revenue by Countries (2014-2019) (Million US$) Table North America Age Related Macular Degeneration Drug Revenue Market Share by Countries (2014-2019) Figure 2018 North America Age Related Macular Degeneration Drug Revenue Market Share by Countries Figure United States Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure United States Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (K Units) Figure Canada Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Canada Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Mexico Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Table North America Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table North America Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure 2018 North America Age Related Macular Degeneration Drug Market Share by Product Table North America Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table North America Age Related Macular Degeneration Drug Sales Market Share by End User (2014-2019) Figure 2018 North America Age Related Macular Degeneration Drug Market Share by End User Figure Europe Age Related Macular Degeneration Drug Sales Growth Rate 2014-2019 (K Units) Figure Europe Age Related Macular Degeneration Drug Revenue Growth Rate 2014-2019 (Million US$) Table Europe Age Related Macular Degeneration Drug Sales by Countries (2014-2019) (K Units) Table Europe Age Related Macular Degeneration Drug Sales Market Share by Countries (2014-2019) Figure 2018 Europe Age Related Macular Degeneration Drug Sales Market Share by Countries Table Europe Age Related Macular Degeneration Drug Revenue by Countries (2014-2019) (Million US$) Table Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries Figure Germany Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Germany Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure France Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure France Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure UK Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure UK Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Italy Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Russia Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Table Europe Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table Europe Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure 2018 Europe Age Related Macular Degeneration Drug Market Share by Product Table Europe Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table Europe Age Related Macular Degeneration Drug Sales Market Share by End User (2014-2019) Figure 2018 Europe Age Related Macular Degeneration Drug Market Share by End User Figure Asia Pacific Age Related Macular Degeneration Drug Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Age Related Macular Degeneration Drug Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Age Related Macular Degeneration Drug Sales by Countries (2014-2019) (K Units) Table Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Countries Table Asia Pacific Age Related Macular Degeneration Drug Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Countries Figure China Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure China Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Japan Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Korea Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure India Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure India Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Australia Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Philippines Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Thailand Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Singapore Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Age Related Macular Degeneration Drug Market Share by Product Table Asia Pacific Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Age Related Macular Degeneration Drug Market Share by End User Figure Central & South America Age Related Macular Degeneration Drug Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Age Related Macular Degeneration Drug Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Age Related Macular Degeneration Drug Sales by Countries (2014-2019) (K Units) Table Central & South America Age Related Macular Degeneration Drug Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Age Related Macular Degeneration Drug Sales Market Share by Countries Table Central & South America Age Related Macular Degeneration Drug Revenue by Countries (2014-2019) (Million US$) Table Central & South America Age Related Macular Degeneration Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Age Related Macular Degeneration Drug Revenue Market Share by Countries Figure Brazil Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Brazil Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Argentina Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table Central & South America Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Age Related Macular Degeneration Drug Market Share by Product Table Central & South America Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table Central & South America Age Related Macular Degeneration Drug Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Age Related Macular Degeneration Drug Market Share by End User Figure Middle East and Africa Age Related Macular Degeneration Drug Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Age Related Macular Degeneration Drug Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Age Related Macular Degeneration Drug Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Countries Table Middle East and Africa Age Related Macular Degeneration Drug Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries Figure GCC Countries Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Turkey Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure Egypt Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Age Related Macular Degeneration Drug Sales Growth Rate (2014-2019) (K Units) Figure South Africa Age Related Macular Degeneration Drug Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Age Related Macular Degeneration Drug Sales by Product (2014-2019) (K Units) Table Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Age Related Macular Degeneration Drug Market Share by Product Table Middle East and Africa Age Related Macular Degeneration Drug Sales by End User (2014-2019) (K Units) Table Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Age Related Macular Degeneration Drug Market Share by End User Table Regeneron Pharmaceuticals Company Details Table Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Regeneron Pharmaceuticals Recent Development Table Bayer HealthCare Company Details Table Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer HealthCare Recent Development Table Novartis Company Details Table Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Roche Company Details Table Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table Kanghong Pharma Company Details Table Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Kanghong Pharma Recent Development Table Global Age Related Macular Degeneration Drug Sales Forecast by Regions 2019-2025 (K Units) Table Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Regions 2019-2025 Table Global Age Related Macular Degeneration Drug Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Regions 2019-2025 Table Global Age Related Macular Degeneration Drug Sales Forecast by Product 2019-2025 (K Units) Table Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Product 2019-2025 Table Global Age Related Macular Degeneration Drug Revenue Forecast by Product 2019-2025 (Million US$) Table Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Product 2019-2025 Table Global Age Related Macular Degeneration Drug Sales Forecast by End User 2019-2025 (K Units) Table Global Age Related Macular Degeneration Drug Sales Market Share Forecast by End User 2019-2025 Figure North America Age Related Macular Degeneration Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Age Related Macular Degeneration Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Age Related Macular Degeneration Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Age Related Macular Degeneration Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Age Related Macular Degeneration Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Age Related Macular Degeneration Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Age Related Macular Degeneration Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Age Related Macular Degeneration Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Age Related Macular Degeneration Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Age Related Macular Degeneration Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Age Related Macular Degeneration Drug Value Chain Table Age Related Macular Degeneration Drug Customers List Table Age Related Macular Degeneration Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Regeneron Pharmaceuticals Bayer HealthCare Novartis Roche Kanghong Pharma